Related references
Note: Only part of the references are listed.ENPP2 Promoter Methylation Correlates with Decreased Gene Expression in Breast Cancer: Implementation as a Liquid Biopsy Biomarker
Maria Panagopoulou et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)
Prometastatic Effect of ATX Derived from Alveolar Type II Pneumocytes and B16-F10 Melanoma Cells
Melanie A. Dacheux et al.
CANCERS (2022)
NbNAC42 and NbZFP3 Transcription Factors Regulate the Virus Inducible NbAGO5 Promoter in Nicotiana benthamiana
Yuan-Dun Ke et al.
FRONTIERS IN PLANT SCIENCE (2022)
Dysregulation of lysophospholipid signaling by p53 in malignant cells and the tumor microenvironment
Sue Chin Lee et al.
CELLULAR SIGNALLING (2021)
Atypical E2Fs either Counteract or Cooperate with RB during Tumorigenesis Depending on Tissue Context
Eva Moreno et al.
CANCERS (2021)
Transcriptional activation of ENPP2 by FoxO4 protects cardiomyocytes from doxorubicin-induced toxicity
Ling He et al.
MOLECULAR MEDICINE REPORTS (2021)
Optimization and evaluation of novel tetrahydropyrido[4,3-d] pyrimidine derivatives as ATX inhibitors for cardiac and hepatic fibrosis
Nan Jiang et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2020)
Ectonucleotide pyrophosphatase 2 (ENPP2) plays a crucial role in myogenic differentiation through the regulation by WNT/β-Catenin signaling
Jay Prakash Sah et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2020)
E2F7-EZH2 axis regulates PTEN/AKT/mTOR signalling and glioblastoma progression
Rui Yang et al.
BRITISH JOURNAL OF CANCER (2020)
Loss of FOXF1 expression promotes human lung-resident mesenchymal stromal cell migration via ATX/LPA/LPA1 signaling axis
Pengxiu Cao et al.
SCIENTIFIC REPORTS (2020)
Deregulation of lysophosphatidic acid metabolism in oral cancer promotes cell migration via the up-regulation of COX-2
Mariati Abdul Rahman et al.
PEERJ (2020)
Conservation and divergence of the p53 gene regulatory network between mice and humans
Martin Fischer
ONCOGENE (2019)
A novel synthetic-genetic-array-based yeast one-hybrid system for high discovery rate and short processing time
Chung-Shu Yeh et al.
GENOME RESEARCH (2019)
Cyclin F-dependent degradation of E2F7 is critical for DNA repair and G2-phase progression
Ruixue Yuan et al.
EMBO JOURNAL (2019)
MicroRNA Regulation of the Autotaxin-Lysophosphatidic Acid Signaling Axis
Mandi M. Murph
CANCERS (2019)
Role of autotaxin in cancer stem cells
Dongjun Lee et al.
CANCER AND METASTASIS REVIEWS (2018)
An E2F7-dependent transcriptional program modulates DNA damage repair and genomic stability
Jone Mitxelena et al.
NUCLEIC ACIDS RESEARCH (2018)
Mechanisms of Lysophosphatidic Acid-Mediated Lymphangiogenesis in Prostate Cancer
Pei-Yi Wu et al.
CANCERS (2018)
Mechanisms of transcriptional regulation by p53
Kelly D. Sullivan et al.
CELL DEATH AND DIFFERENTIATION (2018)
Metabolomics analysis identifies sex-associated metabotypes of oxidative stress and the autotaxin-lysoPA axis in COPD
Shama Naz et al.
EUROPEAN RESPIRATORY JOURNAL (2017)
Autotaxin Expression Is Regulated at the Post-transcriptional Level by the RNA-binding Proteins HuR and AUF1
Shuhong Sun et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2016)
Autotaxin Regulates Maintenance of Ovarian Cancer Stem Cells through Lysophosphatidic Acid-Mediated Autocrine Mechanism
Eun Jin Seo et al.
STEM CELLS (2016)
The autotaxin-LPA2 GPCR axis is modulated by γ-irradiation and facilitates DNA damage repair
Andrea Balogh et al.
CELLULAR SIGNALLING (2015)
Lysophospholipid receptor nomenclature review: IUPHAR Review 8
Yasuyuki Kihara et al.
BRITISH JOURNAL OF PHARMACOLOGY (2014)
c-Jun promotes cell migration and drives expression of the motility factor ENPP2 in soft tissue sarcomas
Stefano Sioletic et al.
JOURNAL OF PATHOLOGY (2014)
Comprehensive molecular profiling of lung adenocarcinoma
Eric A. Collisson et al.
NATURE (2014)
Global genomic profiling reveals an extensive p53-regulated autophagy program contributing to key p53 responses
Daniela Kenzelmann Broz et al.
GENES & DEVELOPMENT (2013)
Galectin-3 Contributes to Melanoma Growth and Metastasis via Regulation of NFAT1 and Autotaxin
Russell R. Braeuer et al.
CANCER RESEARCH (2012)
Insights into p53 transcriptional function via genome-wide chromatin occupancy and gene expression analysis
F. Nikulenkov et al.
CELL DEATH AND DIFFERENTIATION (2012)
Constitutive autotaxin transcription by Nmyc-amplified and non-amplified neuroblastoma cells is regulated by a novel AP-1 and SP-mediated mechanism and abrogated by curcumin
Antonietta R. Farina et al.
FEBS LETTERS (2012)
E2F7, a novel target, is up-regulated by p53 and mediates DNA damage-dependent transcriptional repression
Luis A. Carvajal et al.
GENES & DEVELOPMENT (2012)
Autotaxin is induced by TSA through HDAC3 and HDAC7 inhibition and antagonizes the TSA-induced cell apoptosis
Song Li et al.
MOLECULAR CANCER (2011)
Stat3 Mediates Expression of Autotaxin in Breast Cancer
Janeen Azare et al.
PLOS ONE (2011)
Autotaxin delays apoptosis induced by carboplatin in ovarian cancer cells
Susanne Vidot et al.
CELLULAR SIGNALLING (2010)
Sp1 Regulates Chromatin Looping between an Intronic Enhancer and Distal Promoter of the Human Heme Oxygenase-1 Gene in Renal Cells
Jessy Deshane et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Autotaxin expression and its connection with the TNF-alpha-NF-κB axis in human hepatocellular carcinoma
Jian-Min Wu et al.
MOLECULAR CANCER (2010)
Identification of Selective Inhibitors of Cancer Stem Cells by High-Throughput Screening
Piyush B. Gupta et al.
CELL (2009)
A complex intronic enhancer regulates expression of the CFTR gene by direct interaction with the promoter
Christopher J. Ott et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2009)
Autotaxin protects MCF-7 breast cancer and MDA-MB-435 melanoma cells against Taxol-induced apoptosis
N. Samadi et al.
ONCOGENE (2009)
Atypical E2Fs: new players in the E2F transcription factor family
Tim Lammens et al.
TRENDS IN CELL BIOLOGY (2009)
DNA-damage response control of E2F7 and E2F8
L. Panagiotis Zalmas et al.
EMBO REPORTS (2008)
The lysophosphatidic acid type 2 receptor is required for protection
Wenlin Deng et al.
GASTROENTEROLOGY (2007)
Mutant p53 enhances nuclear factor κB activation by tumor necrosis factor α in cancer cells
Lilach Weisz et al.
CANCER RESEARCH (2007)
P53FamTaG: a database resource of human p53, p63 and p73 direct target genes combining in silico prediction and microarray data
Elisabetta Sbisa et al.
BMC BIOINFORMATICS (2007)
Gain of function of mutant p53: The mutant p53/NF-Y protein complex reveals an aberrant transcriptional mechanism of cell cycle regulation
Silvia Di Agostino et al.
CANCER CELL (2006)
Correlations between c-myc gene copy-number and clinicopathological parameters of ovarian tumours
I Dimova et al.
EUROPEAN JOURNAL OF CANCER (2006)
Tumor-derived p53 mutants induce NF-κB2 gene expression
MJ Scian et al.
MOLECULAR AND CELLULAR BIOLOGY (2005)
Integrin α6β4 promotes expression of autotaxin/ENPP2 autocrine motility factor in breast carcinoma cells
M Chen et al.
ONCOGENE (2005)
A genomic approach to the identification and characterization of HOXA13 functional binding elements
CD McCabe et al.
NUCLEIC ACIDS RESEARCH (2005)
Mutant p53 proteins bind DNA in a DNA structure-selective mode
T Gohler et al.
NUCLEIC ACIDS RESEARCH (2005)
Gain of function of a p53 hot spot mutation in a mouse model of Li-Fraumeni syndrome
GA Lang et al.
CELL (2004)
E2F7, a novel E2F featuring DP-independent repression of a subset of E2F-regulated genes
L Di Stefano et al.
EMBO JOURNAL (2003)
The emerging role of lysophosphatidic acid in cancer
GB Mills et al.
NATURE REVIEWS CANCER (2003)
LPA protects intestinal epithelial cells from apoptosis by inhibiting the mitochondrial pathway
WL Deng et al.
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2003)
Identification of genomic DNA sequences bound by mutant p53 protein (Gly245→Ser) in vivo
H Koga et al.
ONCOGENE (2000)
Share Paper
